文献速递免疫规划

转染毒性质粒的婴儿利什曼原虫初次及初次-加强免疫策略在BALB/c小鼠中的评价

Evaluation of prime and prime-boost immunization strategies in BALB/c mice inoculated with Leishmania infantum transfected with toxic plasmids.
PubMed 文献 · Vaccine · 2022-06-02

研究用转染毒性质粒(表达活性牛胰蛋白酶和鸡蛋亲和素)的婴儿利什曼原虫前鞭毛体免疫BALB/c小鼠,比较初次免疫与初次-加强免疫两种方案,以野生型婴儿利什曼原虫攻击后评估脾、肝、骨髓的寄生虫负荷及免疫反应。结果显示初次-加强免疫组在脾、肝、骨髓中寄生虫负荷降低,并出现高水平的IgG、IgG1、IgG2a抗体及白细胞介素-10、肿瘤坏死因子-α和干扰素-γ,提示Th1/Th2混合应答。作者认为该转染寄生虫是抗内脏利什曼病的优秀疫苗候选,攻击前加强免疫可提供更强保护。

要点

  • 初次-加强免疫组小鼠在脾、肝、骨髓中寄生虫负荷降低。
  • 免疫小鼠出现高水平IgG、IgG1、IgG2a抗体及白细胞介素-10、肿瘤坏死因子-α、干扰素-γ。
  • 作者认为转染毒性质粒的婴儿利什曼原虫是抗内脏利什曼病的优秀疫苗候选。

核心结论

  • 转染毒性质粒的婴儿利什曼原虫是抗内脏利什曼病的优秀疫苗候选,攻击前加强免疫可提供更强保护。

研究设计与样本

  • 在BALB/c小鼠中实施两种免疫方案:初次免疫和初次-加强免疫,随后以野生型婴儿利什曼原虫攻击。
  • 评估脾、肝、骨髓的寄生虫负荷,并进行脾和肝的组织病理学分析及体液免疫反应检测。

主要发现

  • 初次-加强免疫组小鼠在脾、肝、骨髓中寄生虫负荷降低,表明两剂转染寄生虫免疫获得满意保护。
  • 观察到高水平IgG、IgG1、IgG2a抗体,以及抗炎细胞因子白细胞介素-10和促炎细胞因子肿瘤坏死因子-α、干扰素-γ,提示Th1/Th2混合应答。
  • 脾中出现多核巨细胞,肝中出现淋巴细胞浸润。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The etiologic agents of visceral leishmaniasis are Leishmania infantum and Leishmania donovani. Despite the variety of drugs available to treat leishmaniasis, most lead to serious adverse effects, and resistance to these drugs has been reported. Currently, no leishmaniasis vaccine is available for humans. That is why the group developed transgenic L. infantum promastigote lines, which express toxic proteins after differentiation into amastigotes. That is why group developed the pFL-AMA plasmid and transfected it into L. Infantum promastigotes. This plasmid was expressed only in the amastigote form of the parasite. Sequences encoding toxic proteins (active bovine trypsin and egg avidin) were inserted in this plasmid, and the transfected parasites died after the differentiation process. In this study, two immunization protocols were performed in BALB/c mice: prime and prime-boost immunization prior to challenge with the wild-type L. infantum (WT). The parasite burdens in the spleen, liver, and bone marrow were evaluated to verify immunological protection. Histopathological analysis of the spleen and liver and the humoral immune response were also performed. The data showed that the parasite burden was reduced in prime-boosted mice in the spleen, liver, and bone marrow, indicating that mice immunized with two doses of the transfected parasites were satisfactorily protected. High levels of IgG, IgG1, and IgG2a antibodies were observed, as well as the presence of anti-inflammatory cytokine Interleukine-10 and pro-inflammatory cytokine Tumor Necrosis Factor-α (TNF-α) and Interferon-γ (IFN - γ) suggesting a Th1/Th2 mix response, in addition to the presence of multinucleated giant cells in the spleen and lymphocyte infiltration in the liver. Therefore, L. infantum transfected with a toxic plasmid is an excellent vaccine candidate against visceral leishmaniasis and the application of a boost before the challenge promotes greater protection against WT L. infantum infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Augusto Sanches Roque G, Esteves Zorgi N, Janaína Soares Rocha F, et al. Evaluation of prime and prime-boost immunization strategies in BALB/c mice inoculated with Leishmania infantum transfected with toxic plasmids. Vaccine. 2022. PMID: 35660330. doi:10.1016/j.vaccine.2022.05.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。